» Articles » PMID: 23267031

Inflammation in Complex Regional Pain Syndrome: a Systematic Review and Meta-analysis

Overview
Journal Neurology
Specialty Neurology
Date 2012 Dec 26
PMID 23267031
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We conducted a systematic review of the literature with meta-analysis to determine whether complex regional pain syndrome (CRPS) is associated with a specific inflammatory profile and whether this is dependent on the duration of the condition.

Methods: Comprehensive searches of the literature using MEDLINE, Embase, Scopus, Web of Science, and reference lists from published reviews identified articles that measured inflammatory factors in CRPS. Two independent investigators screened titles and abstracts, and performed data extraction and risk of bias assessments. Studies were subgrouped by medium (blood, blister fluid, and CSF) and duration (acute and chronic CRPS). Where possible, meta-analyses of inflammatory factor concentrations were performed and pooled effect sizes were calculated using random-effects models.

Results: Twenty-two studies were included in the systematic review and 15 in the meta-analysis. In acute CRPS, the concentrations of interleukin (IL)-8 and soluble tumor necrosis factor receptors I (sTNF-RI) and II (sTNF-RII) were significantly increased in blood. In chronic CRPS, significant increases were found in 1) TNFα, bradykinin, sIL-1RI, IL-1Ra, IL-2, sIL-2Ra, IL-4, IL-7, interferon-γ, monocyte chemoattractant protein-1 (MCP-1), and sRAGE (soluble receptor for advanced glycation end products) in blood; 2) IL-1Ra, MCP-1, MIP-1β, and IL-6 in blister fluid; and 3) IL-1β and IL-6 in CSF. Chronic CRPS was also associated with significantly decreased 1) substance P, sE-selectin, sL-selectin, sP-selectin, and sGP130 in blood; and 2) soluble intercellular adhesion molecule-1 (sICAM-1) in CSF. Most studies failed to meet 3 or more of our quality criteria.

Conclusion: CRPS is associated with the presence of a proinflammatory state in the blood, blister fluid, and CSF. Different inflammatory profiles were found for acute and chronic cases.

Citing Articles

The association between age and acute pain sensitivity in patients with Herpes Zoster.

Wang L, Li A, Lan Z, Xu S, He R, Jiang Z Sci Rep. 2025; 15(1):5495.

PMID: 39952984 PMC: 11828981. DOI: 10.1038/s41598-025-88618-9.


Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review.

Candan B, Gungor S Diagnostics (Basel). 2025; 15(3).

PMID: 39941283 PMC: 11817358. DOI: 10.3390/diagnostics15030353.


Interventional Physiatry in the Complex Regional Pain Syndrome of the Upper Limb Following Herpes Zoster.

Swarnakar R, Saha A, Sarkar A, Ghosh S, Mandal P Cureus. 2024; 16(11):e74081.

PMID: 39712767 PMC: 11661903. DOI: 10.7759/cureus.74081.


Effect of Prednisolone on Clinical and Cytokine mRNA Profiling in Complex Regional Pain Syndrome.

Kalita J, Shukla R, Pandey P J Mol Neurosci. 2024; 74(4):112.

PMID: 39633155 DOI: 10.1007/s12031-024-02290-8.


miRNA packaging into small extracellular vesicles and implications in pain.

DaCunza J, Wickman J, Ajit S Pain Rep. 2024; 9(6):e1198.

PMID: 39450410 PMC: 11500789. DOI: 10.1097/PR9.0000000000001198.


References
1.
Alexander G, Perreault M, Reichenberger E, Schwartzman R . Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome. Brain Behav Immun. 2006; 21(5):668-76. DOI: 10.1016/j.bbi.2006.10.009. View

2.
Czeschik J, Hagenacker T, Schafers M, Busselberg D . TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett. 2008; 434(3):293-8. DOI: 10.1016/j.neulet.2008.01.070. View

3.
Ritz B, Alexander G, Nogusa S, Perreault M, Peterlin B, Grothusen J . Elevated blood levels of inflammatory monocytes (CD14+ CD16+ ) in patients with complex regional pain syndrome. Clin Exp Immunol. 2011; 164(1):108-17. PMC: 3074223. DOI: 10.1111/j.1365-2249.2010.04308.x. View

4.
Hozo S, Djulbegovic B, Hozo I . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13. PMC: 1097734. DOI: 10.1186/1471-2288-5-13. View

5.
Bargetzi M, Lantz M, Smith C, Torti F, Olsson I, Eisenberg S . Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res. 1993; 53(17):4010-3. View